The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| JYNT | -28.95% | -67.4% | -20.07% | +29% |
| S&P | +13% | +86.41% | +13.26% | +232% |
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
Shares of small-cap healthcare company The Joint Corp. have been crushed. Did this create a nice buying opportunity?
Adopting a long-term mindset, while focusing on the fundamentals, will benefit investors in this situation.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $13.38M | -55.7% |
| Gross Profit | $10.27M | -60.7% |
| Gross Margin | 76.77% | -9.8% |
| Market Cap | $146.38M | -14.7% |
| Market Cap / Employee | $0.20M | 0.0% |
| Employees | 736 | -7.3% |
| Net Income | $0.29M | 109.2% |
| EBITDA | $0.96M | -48.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $30.71M | 39.6% |
| Accounts Receivable | $2.90M | -32.5% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.90M | -69.2% |
| Short Term Debt | $0.19M | -94.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -0.40% | 18.5% |
| Return On Invested Capital | 1.26% | -8.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $1.46M | -54.6% |
| Operating Free Cash Flow | $1.77M | -48.6% |
| Metric | Q3 2025 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 75.42 | - | |||
| Price to Book | 7.78 | 10.57 | 8.87 | 6.29 | -24.78% |
| Price to Sales | 1.52 | 2.15 | 2.49 | 2.70 | 90.46% |
| Price to Tangible Book Value | 9.81 | 10.57 | 8.87 | 6.29 | -40.37% |
| Price to Free Cash Flow TTM | 19.33 | 106.44 | 52.56 | 89.99 | 302.28% |
| Enterprise Value to EBITDA | 109.33 | -764.41 | -659.45 | 122.89 | 44.02% |
| Free Cash Flow Yield | 5.2% | 0.9% | 1.9% | 1.1% | -75.14% |
| Return on Equity | -21.6% | -26.0% | -16.2% | -1.4% | -97.73% |
| Total Debt | $0.80M | $2.25M | $2.17M | $2.09M | -77.81% |
No podcast episodes available.
JYNT earnings call for the period ending September 30, 2020.
JYNT earnings call for the period ending June 30, 2020.
JYNT earnings call for the period ending March 31, 2020.
JYNT earnings call for the period ending December 31, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
